Brainsway Ltd Total Assets
Brainsway Ltd total assets. Based on the latest financial reports, Brainsway Ltd (BWAY) holds total assets worth ILA121.97 Million ILA (≈ $327.01K USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Brainsway Ltd worth for the company's overall valuation and market capitalisation.
Total Assets of Brainsway Ltd (2012–2025)
Total assets of Brainsway Ltd from 2012 to 2025. This chart illustrates how Brainsway Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Brainsway Ltd for real-time trading data and today's change.
Brainsway Ltd - Asset Composition Analysis
Brainsway Ltd Total Assets Breakdown (December 2025)
Brainsway Ltd total assets breakdown as of December 2025. Brainsway Ltd's total assets of ILA121.97 Million consist of 75.2% current assets and 24.8% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 60.2% |
| Accounts Receivable | ILA4.11 Million | 3.6% |
| Inventory | ILA7.14 Million | 6.3% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Brainsway Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore how liquid is Brainsway Ltd's working capital to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Brainsway Ltd's current assets represent 75.2% of total assets in 2025, a decrease from 93.0% in 2012.
- Cash Position: Cash and equivalents constituted 60.2% of total assets in 2025, up from 40.9% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 6.3% of total assets.
Brainsway Ltd Competitors by Total Assets
Key competitors of Brainsway Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
GN Store Nord
CO:GN
|
Denmark | Dkr29.23 Billion |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
|
China | CN¥1.86 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$123.37 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
VIROMED MEDICAL NA O.N.
XETRA:VME
|
Germany | €13.91 Million |
|
Affluent Medical SAS
PA:AFME
|
France | €59.84 Million |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Brainsway Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.59 | 3.51 | 8.37 |
| Quick Ratio | 3.27 | 3.34 | 8.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA58.75 Million | ILA63.98 Million | ILA57.10 Million |
Brainsway Ltd - Advanced Valuation Insights
This section examines the relationship between Brainsway Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.76 |
| Latest Market Cap to Assets Ratio | 3.49 |
| Asset Growth Rate (YoY) | 19.7% |
| Total Assets | ILA112.94 Million |
| Market Capitalization | $394.54 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Brainsway Ltd's assets at a significant premium (3.49x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Brainsway Ltd's assets grew by 19.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Brainsway Ltd (2012–2025)
The table below shows the annual total assets of Brainsway Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ILA112.94 Million ≈ $302.79K |
+19.75% |
| 2024-12-31 | ILA94.32 Million ≈ $252.86K |
+49.77% |
| 2023-12-31 | ILA62.97 Million ≈ $168.83K |
-2.33% |
| 2022-12-31 | ILA64.48 Million ≈ $172.86K |
-14.86% |
| 2021-12-31 | ILA75.73 Million ≈ $203.03K |
+122.67% |
| 2020-12-31 | ILA34.01 Million ≈ $91.18K |
-12.20% |
| 2019-12-31 | ILA38.74 Million ≈ $103.85K |
+64.12% |
| 2018-12-31 | ILA23.60 Million ≈ $63.28K |
-12.68% |
| 2017-12-31 | ILA27.03 Million ≈ $72.47K |
+35.39% |
| 2016-12-31 | ILA19.96 Million ≈ $53.52K |
-10.25% |
| 2015-12-31 | ILA22.24 Million ≈ $59.63K |
-13.69% |
| 2014-12-31 | ILA25.77 Million ≈ $69.09K |
+44.40% |
| 2013-12-31 | ILA17.85 Million ≈ $47.85K |
+66.98% |
| 2012-12-31 | ILA10.69 Million ≈ $28.65K |
-- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more